NCT03602430View on ClinicalTrials.gov

Cholecalciferol on Hemodialysis Patients

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 1, 2018

Primary Completion Date

September 15, 2018

Study Completion Date

September 28, 2018

Conditions
Hemodialysis ComplicationVitamin D DeficiencyVascular Calcification
Interventions
DRUG

Cholecalciferol

Native vitamin D dose of 200IU to be given once per month to hemodialysis patients

DRUG

Placebo

A Placebo ampule will be given to hemodialysis patients once per month with their standard treatment for 3 months period. Same color, odor and size, only without the active constituent.

Trial Locations (1)

Unknown

Ain Shams University Hospital, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT03602430 - Cholecalciferol on Hemodialysis Patients | Biotech Hunter | Biotech Hunter